[Preparation of brain targeted immunoliposomes]

Area of Science:

• Biotechnology
• Gene Therapy
• Nanomedicine

Background:

• Developing effective non-viral gene delivery vectors is crucial for treating neurological disorders.
• The blood-brain barrier (BBB) presents a significant obstacle for delivering therapeutic agents to the brain.

Purpose of the Study:

• To create an effective non-viral transduction vector for delivering exogenous genes into the brain.
• To develop a vector that can be administered intravenously and penetrate the blood-brain barrier.

Main Methods:

• Optimization of material proportions, oil phase type, water-oil ratio, phosphatides-cholesterol ratio, steaming temperature, and ultrasonic parameters.
• Synthesis of immunoliposomes encapsulating the LacZ gene.
• Intravenous infusion of immunoliposomes into rats and detection of beta-galactosidase expression via histochemistry staining.

Main Results:

• The optimal synthesis conditions for immunoliposomes were determined, including a phosphatides-cholesterol ratio of 1:1 and a lipids/drug ratio of 100:1.
• The optimized immunoliposomes achieved an entrapment rate of 87.24% and an antibody coupling rate of 69%.
• Successful gene delivery and expression of the LacZ gene were observed in the brain and peripheral organs of rats post-infusion.

Conclusions:

• Gene-delivering immunoliposomes were successfully synthesized using optimized material proportions.
• This non-viral vector demonstrates the ability to penetrate the blood-brain barrier and deliver exogenous genes for expression in the brain.
• The developed immunoliposomes hold significant promise for the gene therapy of cerebral diseases.